First Time Loading...

Marinus Pharmaceuticals Inc
NASDAQ:MRNS

Watchlist Manager
Marinus Pharmaceuticals Inc Logo
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Watchlist
Price: 1.48 USD -1.99% Market Closed
Updated: May 7, 2024

Marinus Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Marinus Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Cash from Operating Activities
-$118m
CAGR 3-Years
-25%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$23.2B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.7B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$14.8B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$3.7B
CAGR 3-Years
-22%
CAGR 5-Years
-7%
CAGR 10-Years
-4%

See Also

What is Marinus Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-118m USD

Based on the financial report for Dec 31, 2023, Marinus Pharmaceuticals Inc's Cash from Operating Activities amounts to -118m USD.

What is Marinus Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-33%

Over the last year, the Cash from Operating Activities growth was -5%. The average annual Cash from Operating Activities growth rates for Marinus Pharmaceuticals Inc have been -25% over the past three years , -33% over the past five years .